MedTrace Logo

Triage - Symptoms and Other Predictors in an All-comer Emergency Department Population; (EKBB 236/13)

NCT03892551 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7309

Last updated 2022-05-25

No results posted yet for this study

Summary

This study is to develop a tool capable of improved risk prediction regarding the 30-day mortality. Based on vital signs, impaired mobility on presentation (IMOP), Clinical Frailty Scale (CFS) and patients' symptomatology three risk categories (low, intermediate, high risk) will be established.

Conditions

  • Triage Risk Stratification

Interventions

OTHER

Assessment of symptoms patients presenting when admitted to ED

Questionnaire with a predefined list of 35 symptoms

OTHER

Reason for patient presentation at ED

Exploratory interview assessing reason for patient presentation at ED

OTHER

physicians rating of severity of illness

numeric scale ranging from 0 (perfect condition) to 10 (extremely ill)

DIAGNOSTIC_TEST

Assessment of vital signs

Assessment of vital signs (heart rate, blood pressure, body temperature, respiration rate, peripheral capillary haemoglobin oxygen saturation)

OTHER

Clinical Frailty Scale

Assessment of frailty by Clinical Frailty Scale (CFS): assess patients' frailty level from 1, very fit, to 9, terminally ill

OTHER

Impaired mobility on presentation (IMOP)

Assessment of IMOP: defined as being unable to stand unaided or walk without help

OTHER

Assessment of suspected diagnosis and differential diagnoses

Assessment of treating physician's suspected diagnosis and differential diagnoses. Answers will be recorded in free text form.

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Roland Bingisser, Prof. Dr. · Department of Emergency Medicine, University Hospital Basel

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-18
Primary Completion
2020-11-30
Completion
2020-11-30

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03892551 on ClinicalTrials.gov